Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophia Stock
Observed names:
S Stock,
Stock, Sophia
Institutions:
German Cancer Research Center,
LMU Klinikum,
Deutsches Konsortium für Translationale Krebsforschung,
Ludwig-Maximilians-Universität München
Observed institutions:
German Cancer Research Center,
Center for Integrated Protein Science Munich,
University Hospital Heidelberg,
LMU Klinikum,
German Center for Lung Research,
Deutsches Konsortium für Translationale Krebsforschung,
Ludwig-Maximilians-Universität München
show all 7
ORCID:
0000-0002-5072-5013
Observed ORCID:
0000-0002-5072-5013
OpenAlex ID:
A5008214645
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
2024
·
Sebastian B. Lacher
, Janina Dörr
, et al.
·
Nature
·
214
PDF
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
2019
·
Sophia Stock
, Michael Schmitt
, et al.
·
International Journal of Molecular Sciences
·
142
PDF
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
2023
·
Adrian Gottschlich
, Moritz Thomas
, et al.
·
Nature Biotechnology
·
122
PDF
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
2018
·
Jean-Marc Hoffmann
, Maria-Luisa Schubert
, et al.
·
Frontiers in Immunology
·
103
PDF
Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients
2020
·
Fuli Fan
, Hyeon Joo Yoo
, et al.
·
International Journal of Cancer
·
82
PDF
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
2019
·
Sophia Stock
, Rudolf Übelhart
, et al.
·
International Journal of Cancer
·
82
PDF
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
2023
·
Kai Rejeski
, Ariel Perez
, et al.
·
Science Advances
·
63
PDF
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
2019
·
Wenjie Gong
, Jean-Marc Hoffmann
, et al.
·
Cancer Immunology Immunotherapy
·
56
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function
2022
·
Matthias Seifert
, Mohamed-Reda Benmebarek
, et al.
·
British Journal of Cancer
·
48
PDF
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
2022
·
Sophia Stock
, Mohamed-Reda Benmebarek
, et al.
·
Journal for ImmunoTherapy of Cancer
·
30
PDF
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies
2021
·
Sanmei Wang
, Leopold Sellner
, et al.
·
Oncology Reports
·
30
PDF
Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
2025
·
Sophia Stock
, Veit L. Bücklein
, et al.
·
HemaSphere
·
29
PDF
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control
2023
·
Sophia Stock
, Anna‐Kristina Klüver
, et al.
·
International Journal of Cancer
·
28
PDF
Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners
2022
·
Sophia Stock
, Anna-Kristina Kluever
, et al.
·
Biomedicines
·
25
PDF
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells
2018
·
Sophia Stock
, Jean-Marc Hoffmann
, et al.
·
Human Gene Therapy
·
24
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
2024
·
Florian Märkl
, Christoph Schultheiß
, et al.
·
Nature Communications
·
15
PDF
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
2025
·
Adrian Gottschlich
, Ruth Grünmeier
, et al.
·
Blood
·
14
PDF
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy
2025
·
Gloria Iacoboni
, Kai Rejeski
, et al.
·
Leukemia
·
9
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma
2023
·
Florian Märkl
, Mohamed-Reda Benmebarek
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours
2026
·
Janina Dörr
, Lisa Gregor
, et al.
·
Nature Biomedical Engineering
·
7
PDF
ESCRT machinery: role of membrane repair mechanisms in escaping cell death
2022
·
Lisa Gregor
, Sophia Stock
, et al.
·
Signal Transduction and Targeted Therapy
·
7
PDF
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
2024
·
Sophia Stock
, Luisa Fertig
, et al.
·
Cancer Immunology Immunotherapy
·
4
PDF
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
2021
·
Wenjie Gong
, Lei Wang
, et al.
·
Cells
·
4
PDF
Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers
2025
·
Giulia Magno
, Kai Rejeski
, et al.
·
Blood Advances
·
3
PDF
Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML
2023
·
Sophia Stock
, Thaddaeus Strzalkowski
, et al.
·
Blood
·
3
Show more works
View as search
Works count:
54
Citation count:
1,165
H-index:
15
I10-index:
17
Year
Topic
Type